Measuring neuropsychological change following breast cancer treatment: An analysis of statistical models

Journal of Clinical and Experimental Neuropsychology

Volumn 31, Issue 1, 2009, Pages 73-89

  Ouimet, L A ^a   Stewart, A ^a   Collins, B ^b   Schindler, D ^a   Bielajew, C ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Breast cancer; Chemotherapy; Cognitive impairment; Neuropsychological assessment; Standardized regression based approach; Statistical methods

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER STAGING; COGNITIVE DEFECT; CONTROLLED STUDY; COVARIANCE; DEMOGRAPHY; DETERIORATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TEST; PATIENT ASSESSMENT; PATIENT PARTICIPATION; PRIORITY JOURNAL; QUALITY OF LIFE; STATISTICAL MODEL; UNIVARIATE ANALYSIS;

AGED; BREAST NEOPLASMS; CROSS-SECTIONAL STUDIES; DRUG THERAPY; FEMALE; HORMONES; HUMANS; MENTAL PROCESSES; MIDDLE AGED; MODELS, STATISTICAL; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 57749115795     PISSN: 13803395     EISSN: 1744411X     Source Type: Journal    
DOI: 10.1080/13803390801992725     Document Type: Article

References (69)

1. Ahles, T. A., Saykin, A. J., Furstenberg, C. T., Cole, B., Mott, L. A., Skalla, K., et al. (2002). Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. Journal of Clinical Oncology, 20, 485-493.
2. Ahles, T. A., Tope, D. M., Furstenberg, C., Hann, D., & Mills, L. (1996). Psychologic and neuropsychologic impact of autologous bone marrow transplantation. Journal of Clinical Oncology, 14, 1457-1462.
3. Ammons, R. B., & Ammons, C. H. (1962). The Quick Test (QT): Provisional manual. Psychological Reports. Monograph Supplement 1-VII, 111-161.
4. Anderson-Hanley, C., Sherman, M. L., Riggs, R., Agocha, V. B., & Compas, B. E. (2003). Neuropsychological effects of treatments for adults with cancer: A meta- analysis and review of the literature. Journal of the International Neuropsychological Society, 9, 967-982.
5. Bender, C. M., Sereika, S. M., Berga, S. L., Vogel, V. G., Brufsky, A. M., Paraska, K. K., et al. (2006). Cognitive impairment associated with adjuvant therapy in breast cancer. Psycho-Oncology, 15, 422-430.
6. Brezden, C. B., Phillips, K., Abdolell, M., Bunston, T., & Tannock, I. F. (2000). Cognitive function in breast cancer patients receiving adjuvant chemotherapy. Journal of Clinical Oncology, 18, 2695-2701.
7. Castellon, S. A., Ganz, P. A., Bower, J. E., Peterson, L., Abraham, L., & Greendale, G. A. (2004). Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. Journal of Clinical and Experimental Neuropsychology. 26, 955-969.
8. Castellon, S. A., Silverman, D. H. D., & Ganz, P. A. (2005). Breast cancer treatment and cognitive functioning: Current status and future challenges in assessment. Breast Cancer Research and Treatment, 92, 299-206.
9. Daly, E., Komaroff, A. L., Bloomingdale, K., Wilson, S., & Albert, M. S. (2001). Neuropsychological function in patients with chronic fatigue syndrome, multiple sclerosis, and depression. Applied Neuropsychology, 8, 12-20.
10. Dick, F., Semple, S., Soutar, A., Osborne, A., Cherrie, J. W., & Seaton, A. (2004). Is colour vision impairment associated with cognitive impairment in solvent exposed workers. Occupational and Environmental Medicine, 61, 76-78.
11. Donovan, K. A., Small, B. J., Andrykowski, M. A., Schmitt, F. A., Munster, P., & Jacobsen, P. B. (2005). Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma. Cancer, 104, 2499-2507.
12. Faust, D., & Fogel, B. S. (1989). The development and initial validation of a sensitive bedside cognitive screening test. Journal of Nervous and Mental Disease, 177, 25-31.
13. Fogel, B. S. (1991). The High Sensitivity Cognitive Screen. International Psychogeriatrics, 3, 273-288.
14. Freeman, J. R., & Broshek, D. K. (2002). Assessing cognitive dysfunction in breast cancer: What are the tools? Clinical Breast Cancer, 3, 591-599.
15. Frerichs, R. J., & Tuokko, H. A. (2006). Reliable change scores and their relation to perceived change in memory: Implications for the diagnosis of mild cognitive impairment. Archives of Clinical Neuropsychology, 21, 109-115.
16. Frigon, J. Y., & Laurencelle, L. (1993). An analysis of covariance: A proposed algorithm. Educational and Psychological Measurement, 53, 1-18.
17. Gottschalk, L. A., Holcombe, R. F., Jackson, D., & Bechtel, R. J. (2003). The effects of anticancer chemotherapeutic drugs on cognitive function and other neuropsychiatric dimensions in breast cancer patients. Methods and Findings in Experimental and Clinical Pharmacology, 25, 117-122.
18. Heaton, R. K., Temkin, N., Dikmen, S., Avitable, N., Taylor, M. J., Marcotte, T. D., et al. (2001). Detecting change: A comparison of three neuropsychological methods, using normal and clinical samples. Archives of Clinical Neuropsychology, 16, 75-91.
19. Hermelink, K., Untch, M., Lux, M. P., Kreienberg, R., Beck, T., Bauerfeind, I., et al. (2007). Cognitive function during neoadjuvant chemotherapy for breast cancer. Cancer, 109, 1905-1913.
20. Hurria, A., & Lachs, M. (2007). Is cognitive dysfunction a complication of adjuvant chemotherapy in the older patient with breast cancer? Breast Cancer Research and Treatment, 103, 259-268.
21. Isella, V., Atzeni, L., Iurlaro, S., Villa, M. L., Russo, A., Forapani, E., et al. (2003). Assessing clinically relevant cognitive decline: Preliminary data on a new method. Neurological Sciences, 24, 236-241.
22. Jenkins, V., Shilling, V., Deutsch, G., Bloomfield, D., Morris, R., Allan, S., et al. (2006). A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. British Journal of Cancer, 94, 828-834.
23. Jacobson, N. S., Follette, W. C., & Revenstorf, D. (1984). Psychotherapy outcome research: Methods for reporting variability and evaluating clinical significance. Behavior Therapy, 15, 336-352.
24. Jacobson, N. S., & Truax, P. (1991). Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology, 59, 12-19.
25. Jansen, C. E., Miaskowski, C., Dodd, M., & Dowling, G. (2005). Chemotherapy-induced cognitive impairment in women with breast cancer: A critique of the literature. Oncology Nursing Forum, 32, 329-342.
26. Jenkins, V., Shilling, V., Deutsch, G., Bloomfield, D., Morris, R., Allan, S., et al. (2006). A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. British Journal of Cancer, 94, 828-834.
27. Jenkins, V., Shilling, V., Fallowfield, L., Howell, A., & Hutton, S. (2004). Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study. Psycho-Oncology, 13, 61-66.
28. Joyce, E. M., Hutton, S. B., Mutsatsa, S. H., & Barnes, T. R. (2005). Cognitive heterogeneity in first-episode schizophrenia. British Journal of Psychiatry, 187, 516-522.
29. Kirk, R. E. (1968). Experimental design: Procedures for the behavioral sciences. Belmont, CA: Brooks/Cole Publishing Company.
30. Kreukels, B. P., Schagen, S. B., Ridderinkhof, K. R., Boogerd, W., Lamburger, H. L., & van Dam, F. S. (2005). Electrophysiological correlates of information processing in breast-cancer patients treated with adjuvant chemotherapy. Breast Cancer Research and Treatment, 94, 53-61.
31. LoGalbo, A., Sawrie, S., Roth, D. L., Kuzniecky, R., Knowlton, R., Faught, E., et al. (2005). Verbal memory outcome in patients with normal preoperative verbal memory and left mesial temporal sclerosis. Epilepsy & Behavior, 6, 337-341.
32. Lezak, M. D., Howieson, D. B., & Loring, D. W. (2004). Neuropsychological assessment (4th ed.). New York: Oxford University Press.
33. Mar Fan, H. G., Houede-Tchen, N., Yi, Q., Chemerynsky, I., Downie, F. P., Sabate, K., et al. (2005). Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1 and 2 year follow-up of a prospective controlled study. Journal of Clinical Oncology, 23, 8025-8032.
34. Martin, R., Griffith, H. R., Sawrie, S., Knowlton, R., & Faught, E. (2006). Determining empirically based self-reported cognitive change: Development of reliable change indices and standardized regression-based change norms for the multiple abilities self-report questionnaire in an epilepsy sample. Epilepsy & Behavior, 8, 239-245.
35. Martin, R., Sawrie, S., Gilliam, F., Mackey, M., Faught, E., Knowlton, R., et al. (2002). Determining reliable cognitive change after epilepsy surgery: Development of reliable change indices and standardized regression-based change norms for the WMS-III and WAIS-III. Epilepsia, 43, 1551-1558.
36. McCrea, M., Barr, W. B., Guskiewica, K., Randolph, C., Marshall, S. W., Cantu, R., et al. (2005). Standard regression-based methods for measuring recovery after sport-related concussion. Journal of the International Neuropsychological Society, 11, 58-69.
37. McNair, D. M., Lorr, M., & Droppleman, L. F. (1992). Manual for the Profile of Mood States. San Diego, CA: Educational and Industrial Service.
38. McSweeney, A. J., Naugle, R. I., Chelune, G. J., & Lunders, H. (1993). "T scores for change": An illustration of a regression approach to depicting change in clinical neuropsychology. The Clinical Neuropsychologist, 7, 300-312.
39. National Cancer Institute. (2007). Finding cancer statistics: Cancer stat fact sheets - Cancer of the breast. Retrieved November 19, 2007, from http://seer.cancer.gov/statfacts/html/breast.html
40. Nelson, H. E., & McKenna, P. (1975). The use of current reading ability in the assessment of dementia. British Journal of Social and Clinical Psychology, 14, 259-267.
41. Olin, J. J. (2001). Cognitive function after systemic therapy for breast cancer. Oncology, 15, 613-624.
42. Peace, K. A., Orme, S. M., Padayatty, S. J., Godfrey, H. P. D., & Belchetz, P. E. (1998). Cognitive dysfunction in patients with pituitary tumour who have been treated with transfrontal or transsphenoidal surgery or medication. Clinical Endocrinology, 49, 391-396.
43. Public Health Agency of Canada. (2007). Breast Cancer. Retrieved November 19, 2007, from http://www.phac-aspc.gc.ca/ccdpc-cpcmc/bc-cds/index_e. html
44. Raymond, P. D., Hinton-Bayre, A. D., Radel, M., Ray, M. J., & Marsh, N. A. (2006). Assessment of statistical change criteria used to define significant change in neuropsychological test performance following cardiac surgery. European Journal of Cardio-Thoracic Surgery, 29, 82-88.
45. Sawrie, S. M. (2002). Analysis of cognitive change: A commentary on Keith et al. (2002). Neuropsychology, 16, 429-431.
46. Sawrie, S. M., Marson, D. C., Boothe, A. L., & Harrell, L. E. (1999). A method for assessing clinically relevant individual cognitive change in older adult populations. Journal of Gerontology, 54B, 116-124.
47. Saykin, A. J., Ahles, T. A., & McDonald, B. C. (2003). Mechanisms of chemotherapy-induced cognitive disorders: Neuropsychological, pathophysiological, and neuroimaging perspectives. Seminars in Clinical Neuropsychiatry, 8, 201-216.
48. Schagen, S. B., Hamburger, H. L., Muller, M. J., Boogerd, W., & van Dam, F. S. (2001). Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function. Journal of Neuro-Oncology, 51, 159-165.
49. Schagen, S. B., Muller, M. J., Boogerd, W., Rosenbrand, R. M., van Rhijn, D., Rodenhuis, S., et al. (2002). Late effects of adjuvant chemotherapy on cognitive function: A follow-up study in breast cancer patients. Annals of Oncology, 13, 1387-1397.
50. Schagen, S. B., van Dam, F. S., Muller, M. J., Boogerd, W. Lindeboom, J., & Bruning, P. F. (1999). Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer, 85, 640-650.
51. Scherwath, A., Mehnert, A., Schleimer, B., Schirmer, L., Fehlauer, F., Kreienberg, R., et al. (2006). Neuropsychological function in high-risk breast cancer survivors after stem-cell supported high-dose therapy versus standard-dose chemotherapy: Evaluation of long- term treatment effects. Annals of Oncology, 17, 415-423.
52. Schilder, C., & Schagen, S. (2007). Effects of hormonal therapy on cognitive functioning in breast cancer patients: A review of the literature. Minerva Ginecologica, 59, 387-401.
53. Servaes, P., Verhagen, C. A., & Bleijenberg, G. (2002). Relations between fatigue, neuropsychological functioning, and physical activity after treatment for breast carcinoma. Cancer, 95, 2017-2026.
54. Shilling, V., & Jenkins, V. (2007). Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer. European Journal of Oncology Nursing, 11, 6-15.
55. Shilling, V., Jenkins, V., Fallowfield, L., & Howell, T. (2003). The effects of hormone therapy on cognition in breast cancer. Journal of Steroid Biochemistry & Molecular Biology, 86, 405-412.
56. Shilling, V., Jenkins, V., Morris, R., Deutsch, G., & Bloomfield, D. (2005). The effects of adjuvant chemotherapy on cognition in women with breast cancer - preliminary results of an observational longitudinal study. The Breast, 14, 142-150.
57. Shilling, V., Jenkins, V., & Trapala, I. S. (2006). The (mis)classification of chemo-fog - methodological inconsistencies in the investigation of cognitive impairment after chemotherapy. Breast Cancer Research and Treatment, 95, 125-129.
58. Stewart, A., Bielajew, C., Collins, B., Parkinson, M., & Tomiak, E. (2006). A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. Clinical Neuropsychology, 20, 76-89.
59. Stewart, A., Collins, B., Mackenzie, J., Tomiak, E., Verma, S., & Bielajew, C. (2008). The cognitive effects of adjuvant chemotherapy in early stage breast cancer: A prospective study. Psycho-Oncology, 17, 122-130.
60. Tabachnick, B. G., & Fidell, L. S. (2006). Using multivariate statistics (5th ed.). Boston: Allyn and Bacon.
61. Tchen, N., Juffs, H. G., Downie, F. P., Yi, Q., Hu, H., Chemerynsky, I., et al. (2003). Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. Journal of Clinical Oncology, 22, 4175-4183.
62. Temkin, N. R., Heaton, R. K., Grant, I., & Dikmen, S. S. (1999). Detecting significant change in neuropsychological test performance: A comparison of four models. Journal of the International Neuropsychological Society, 5, 357-369.
63. Tiersky, L. A., Johnson, S. K., Lange, G., Natelson, B. H., & DeLuca, J. (1997). Neuropsychology of chronic fatigue syndrome: A critical review. Journal of Clinical and Experimental Neuropsychology, 19, 560-586.
64. van Dam, F. S., Schagen, S. B., Muller, M. J., Boogerd, W., Wall, E., Droogleever Fortuyn, et al. (1998). Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: High-dose versus standard-dose chemotherapy. Journal of the National Cancer Institute, 90, 210-218.
65. Vardy, J., Rourke, S., & Tannock, I. F. (2007). Evaluation of cognitive function associated with chemotherapy: A review of published studies and recommendations for future research. Journal of Clinical Oncology, 25, 2455-2463.
66. Vardy, J., Wong, K., Yi, Q., Park, A., Maruff, P., Wagner, L., et al. (2006). Assessing cognitive function in cancer patients. Supportive Care in Cancer, 14, 1111-1118.
67. Wefel, J. S., Lenzi, R., Theriault, R. Buzdar, A. U., Cruickshank, S., & Meyers, C. A. (2004a). "Chemobrain" in breast carcinoma? A prologue. Cancer, 101, 466-475.
68. Wefel, J. S., Lenzi, R., Theriault, R., Davis, R. N., & Meyers, C. A. (2004b). The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma. Cancer, 100, 2292-2299.
69. Wieneke, M. H., & Dienst, E. R. (1995). Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psycho-Oncology, 4, 61-66.